13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000950123-23-010821
Total Value
$1.38B
Positions
18
Other Managers
3
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 9,662,114 | $998.0M | 72.44% |
| 2 | Sana Biotechnology Inc | SANA | 15,909,178 | $61.6M | 4.47% |
| 3 | Denali Therapeutics Inc | DNLI | 2,619,968 | $54.0M | 3.92% |
| 4 | Omega Therapeutics Inc | 68217N105 | 22,240,723 | $47.8M | 3.47% |
| 5 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $46.7M | 3.39% |
| 6 | Sana Biotechnology Inc | SANA | 9,092,678 | $35.2M | 2.55% |
| 7 | Seres Therapeutics Inc | MCRB | 14,664,169 | $34.9M | 2.53% |
| 8 | Evelo Biosciences Inc | EVEX-WT | 5,831,974 | $22.9M | 1.66% |
| 9 | Seres Therapeutics Inc | MCRB | 8,452,876 | $20.1M | 1.46% |
| 10 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $16.7M | 1.21% |
| 11 | Omega Therapeutics Inc | 68217N105 | 6,984,856 | $15.0M | 1.09% |
| 12 | Axcella Health Inc | 05454B204 | 725,684 | $7.6M | 0.55% |
| 13 | Evelo Biosciences Inc | EVEX-WT | 1,590,385 | $6.2M | 0.45% |
| 14 | Axcella Health Inc | 05454B204 | 444,375 | $4.6M | 0.34% |
| 15 | Syros Pharmaceuticals Inc | 87184Q206 | 700,000 | $2.8M | 0.20% |
| 16 | Evelo Biosciences Inc | EVEX-WT | 510,265 | $2.0M | 0.15% |
| 17 | Syros Pharmaceuticals Inc | 87184Q206 | 293,848 | $1.2M | 0.08% |
| 18 | Moderna Inc | MRNA | 3,924 | $405,310 | 0.03% |